Four equities have emerged as potential rebound candidates after a sharp August decline, trading near oversold levels with consensus price targets well above current valuations.
AppLovin (APP) fell 28% over the past month to $308.77, pushing its Relative Strength Index to 24.0—textbook oversold territory near its 52-week low. Piper Sandler reduced its target to $325 from $385 while maintaining a Neutral rating, citing an expectations reset that could set the stage for a near-term recovery. The stock carries a 23.7x P/E ratio and a Piotroski Score of 9, indicating strong fundamental health.
Signet Jewelers (SIG) declined 9.9% over the past month to $81.02, with a 33.9 RSI and a 11.3x P/E. Fair value estimates suggest 50.7% upside, while analyst targets imply 30.8% potential gains. The company has repurchased shares and increased dividends for four consecutive years, with six analysts revising earnings estimates upward.
Cirrus Logic (CRUS) dropped 16.2% in a month to $116.90, trading at a 27.0 RSI and 14.3x P/E. Fair value models indicate 36.8% upside, with analyst targets pointing to 41.1% potential gains. The company maintains a net cash position and has accelerated share buybacks, though four analysts trimmed earnings forecasts citing semiconductor cycle risks.
Smithfield Foods (SFD) fell 14.8% over the past month to $22.28, with a 27.3 RSI and an 8.9x P/E—the lowest among the four highlighted stocks. Fair value estimates suggest 24.1% upside, while analyst targets indicate 34.6% potential gains.
The screening process evaluated more than 50 candidates using criteria including RSI below 30, positive fair value, reasonable P/E ratios, and analyst targets exceeding current prices. Notable exclusions include Moderna (MRNA), which surged 110% in a week despite a negative P/E and fair value downside of 44%, and Amylyx (AMLX), which rose 83% with a 59% fair value downside.
